Neil Lerner insider trades

Open-market stock purchases and sales by Neil Lerner, Chief Accounting Officer at Compass Therapeutics, Inc, from SEC Form 4 filings since Mar 17, 2011.

Track record: 0% of 8 scored buys are up 5% or more since purchase, averaging -54%.

Recent trades

DateStockTradeValue
Oct 1, 2026CMPX Compass Therapeutics, IncBought$18.4K
Sep 24, 2026CMPX Compass Therapeutics, IncBought$2.9K
Apr 29, 2026CMPX Compass Therapeutics, IncBought (not open market)$28.4K
Apr 29, 2026CMPX Compass Therapeutics, IncBought$28.4K
Jan 2, 2026CMPX Compass Therapeutics, IncBought (not open market)—
Jan 2, 2026CMPX Compass Therapeutics, IncBought (not open market)$323K

Companies traded

  • CMPX Compass Therapeutics, Inc: 4 buys, last Oct 1, 2026
  • PMD Psychemedics Corp: 4 buys, 3 sales, last Nov 11, 2020

Get free alerts when Neil Lerner files a new trade →